Test moleculares vs lobectomia en pacientes con nódulos tiroideos PAAF: Bethesda III/IV. En Venezuela la balanza en costo se inclinaría a favor de la cirugía.
RT @divot999: AAES members moving thyroid management forward while ultimately decreasing morbidity. With endocrinologist we can improve car…
RT @PittEndoSurg: Honored to have our work in Thyroid highlighted by @TheAAES! @l_yip123 @kiajoynicholson @kellymccmck https://t.co/sxSp9Lt…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @PittEndoSurg: Honored to have our work in Thyroid highlighted by @TheAAES! @l_yip123 @kiajoynicholson @kellymccmck https://t.co/sxSp9Lt…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
RT @divot999: AAES members moving thyroid management forward while ultimately decreasing morbidity. With endocrinologist we can improve car…
RT @PittEndoSurg: Honored to have our work in Thyroid highlighted by @TheAAES! @l_yip123 @kiajoynicholson @kellymccmck https://t.co/sxSp9Lt…
Honored to have our work in Thyroid highlighted by @TheAAES! @l_yip123 @kiajoynicholson @kellymccmck
AAES members moving thyroid management forward while ultimately decreasing morbidity. With endocrinologist we can improve care for patients with thyroid cancer :) @ATALeadership @TheAACE @TheEndoSociety @IAESurgeons
RT @TheAAES: MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find…
MEMBER PUBLICATION HIGHLIGHT - Molecular testing vs diagnostic lobectomy for indeterminate thyroid nodules. Who wins out? Find out more at https://t.co/K8GI0P0dpY. Great work by team @PittEndoSurg! @thyca https://t.co/4zfHh7aopN
RT @PittEndoSurg: Molecular testing is cost-effective relative to diagnostic lobectomy in indeterminate thyroid nodules. Check out our late…
RT @PittEndoSurg: Molecular testing is cost-effective relative to diagnostic lobectomy in indeterminate thyroid nodules. Check out our late…
Gosh my pals are fierce #WomenInMedicine @kiajoynicholson
RT @PittEndoSurg: Molecular testing is cost-effective relative to diagnostic lobectomy in indeterminate thyroid nodules. Check out our late…
RT @PittEndoSurg: Molecular testing is cost-effective relative to diagnostic lobectomy in indeterminate thyroid nodules. Check out our late…
RT @PittEndoSurg: Molecular testing is cost-effective relative to diagnostic lobectomy in indeterminate thyroid nodules. Check out our late…
RT @PittEndoSurg: Molecular testing is cost-effective relative to diagnostic lobectomy in indeterminate thyroid nodules. Check out our late…
Excited to see my first cost-effectiveness analysis in print!
Molecular testing is cost-effective relative to diagnostic lobectomy in indeterminate thyroid nodules. Check out our latest! Molecular Testing Versus Diagnostic Lobectomy in Bethesda III/IV Thyroid Nodules: A Cost-Effectiveness Analysis. - PubMed - NCBI h